LITTLETON, Mass.--(BUSINESS WIRE)--At the first virtual meeting of the American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting, October 23rd to the 29th, Mevion will highlight its research ...

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems presented publicly the first pre-clinical results of its research demonstrating the FLASH effect using a commercial MEVION S250i proton ...

RaySearch Laboratories AB (publ) and Mevion Medical Systems, two companies that are leading the field of proton therapy, announce a collaboration to develop advanced treatment planning techniques for ...

Mevion Medical Systems, a global leader in compact proton therapy, today announced that the world’s first clinical proton therapy treatment delivered inside an existing conventional radiation therapy ...

LITTLETON, Mass., September 15, 2025--(BUSINESS WIRE)--Mevion Medical Systems today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the MEVION S250-FIT™ ...

The MEVION S250-FIT™ creates a new pathway for European cancer centers to integrate proton therapy into existing radiotherapy programs LITTLETON, Mass., May 11, 2026--(BUSINESS WIRE)--Proton therapy ...

Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy CE Marking enables marketing and clinical use of the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. At the American Society for Radiation Oncology meeting in ...

LITTLETON, Mass.–(BUSINESS WIRE)–#ASTRO2021—RaySearch Laboratories AB (publ) and Mevion Medical Systems, two companies that are leading the field of proton therapy, announce a collaboration to develop ...

Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatment environments, ...

Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has ...